Edition:
United Kingdom

Medigus Ltd (MDGS.OQ)

MDGS.OQ on NASDAQ Stock Exchange Capital Market

1.30USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,664
52-wk High
$10.60
52-wk Low
$1.25

Chart for

About

Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices. Its product line includes SRS endoscopy systems for the treatment of gastroesophageal reflux disease (GERD). Medigus' SRS endoscopy system for the treatment of GERD performs an anterior fundoplicat... (more)
No analyst recommendations are available for .

Overall

Beta: 2.58
Market Cap(Mil.): ₪23.03
Shares Outstanding(Mil.): 151.29
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Medigus Q3 revenue falls 14 percent to $117,000

* Q3 revenue fell 14 percent to $117,000 Source text for Eikon: Further company coverage:

24 Nov 2017

BRIEF-Medigus announces pricing of $1.6 mln registered direct offering

* Medigus announces pricing of $1.6 million registered direct

24 Nov 2017

BRIEF-Medigus announces second quarter 2017 financial results

* Medigus Ltd - ‍operating loss for three months ended June 30, 2017, was $1.3 million, compared to $2.7 million in three months ended June 30, 2016​

18 Sep 2017

BRIEF-Medigus broadens availability of MUSE device via deal

* Medigus broadens availability of muse(tm) through distribution agreement with admedics ag in switzerland and liechtenstein

26 Jul 2017

BRIEF-Medigus signs distribution agreement with Izasa Hospital in Spain

* Medigus expands global commercial availability of Muse through distribution agreement with Izasa Hospital, S.L.U. in Spain

19 Jul 2017

Earnings vs. Estimates